Drugdiscovery >> Clinical Trials >> News
4858
Views
title
Promising new therapy for Duchenne muscular dystrophy patients - drugdiscovery.com


In the first study from a double-blind controlled randomized trial, Sarepta Therapeutics’ drug eteplirsen, improved walking performance of DMD patients. Although the first results are promising, future studies will show if this could be the first therapy for DMD to target the underlying cause of the disease.
Read More >>


Tags: Duchenne muscular dystrophy, clinical trials, DMD,Sarepta Therapeutics, eteplirsen - August 11, 2013
Related Articles
3969
Views
GSK’s Duchenne muscular dystrophy failed in late-stage trial GSK’s Duchenne muscular dystrophy failed in late-stage trial
A potential treatment for Duchenne muscular dystrophy, drisapersen, did not meet the study's main goal of generating a statistically significant improvement in a six-minute walking distance test comp Read More >>

Tags: Duchenne muscular dystrophy, drisapersen, new treatment, clinical trial

5912
Views
Cialis as a treatment for Duchenne’s muscular dystrophy? Cialis as a treatment for Duchenne’s muscular dystrophy?
Eli Lilly’s erectile disfunction drug - Cialis, will be tested in a phase III trial for potential benefits in patients with Duchenne’s muscular dystrophy (DMD). Read More >>

Tags: Duchenne’s muscular dystrophy, clinical trial, cialis, Eli Lilly

7544
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

3216
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

17948
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

8250
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

5103
Views
A combination of conventional and gene therapy for treatment of deadly brain cancer A combination of conventional and gene therapy for treatment of deadly brain cancer
A phase I human clinical trial is expected to start early in 2014. Newly diagnosed glioblastoma multiforme patients, along with standard of care that includes chemo-radiotherapy, will also be treated Read More >>

Tags: glioblastoma multiforme, clinical trial, gene therapy, stem cells, oncolytic adenovirus, neural stem cells,HB1.F3 NSC

3021
Views
Clinical Trials: too slow for dying patients? Clinical Trials: too slow for dying patients?
Speed of clinical trials are sometimes too slow for dying patients. What we can do to speed up the process and enable patients to get the medicine on time? Can anything end the lethally slow process? Read More >>

Tags: process, patients, clinical trials

3629
Views
Experimental durg of  Pfizer gives promising results in prevention of community acquired pneumonia Experimental durg of Pfizer gives promising results in prevention of community acquired pneumonia
Pfizer has just finished its landmark stuy over a pnemonia drug. The trial which is based on over 85,000 samples and the new treatment seems to be very effective on patient 65 years and over. Read More >>

Tags: drug; discovery, development, news, Pfizer, CAPITA, clinical trial, CAP, pneumonia, primary endpoint

3514
Views
Incyte's new drug produced promising results for Polycythemia Vera Incyte's new drug produced promising results for Polycythemia Vera
Incyte's Polycythemia Vera drug produced far better results on clinical Phase III trials than the former alternatives of medicine for patients who are resistant to or intolerant of hydroxyurea. Read More >>

Tags: hydroxyurea, Incyte, Polycythemia Vera

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013